- Investor's Business Daily•3 days ago
What should investors take away from the JPMorgan Healthcare Conference? Sentiment is "cautiously optimistic."
- Insider Monkey•4 days ago
TESARO Inc (NASDAQ:TSRO) took a bit of a hit early Thursday morning, as the FDA announced it had issued a complete response letter (CRL) to the company relating to its latest new drug application (NDA) submission. The submission is an attempt to get a drug called rolapitant IV approved for the prevention of delayed nausea […]
- Zacks•4 days ago
TESARO (TSRO) announced that it has received a Complete Response Letter from the FDA regarding its NDA for Varubi IV.
TSRO : Summary for TESARO, Inc. - Yahoo Finance
Tesaro, Inc. (TSRO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Day's Range||148.00 - 157.75|
|52 Week Range||29.51 - 157.77|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-21.35|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|